Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model

  1. Gomis-González, M.
  2. Matute, C.
  3. Maldonado, R.
  4. Mato, S.
  5. Ozaita, A.
Journal:
Genes

ISSN: 2073-4425

Year of publication: 2016

Volume: 7

Issue: 9

Type: Article

DOI: 10.3390/GENES7090056 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus